ClinicalTrials.Veeva

Menu

DNA Damage and Subfertility in Males - Impact on ART Outcome (ReproDNA)

R

Regionshospitalet Viborg, Skive

Status

Enrolling

Conditions

Infertility

Study type

Observational

Funder types

Other

Identifiers

NCT04160208
DFI2019Skivecohort

Details and patient eligibility

About

A obvational prospective cohort study of men undergoing IUI, IVF and ICSI treatment in Denmark. The aim is to asses the impact of sperm DNA damage, measured as DNA fragmentation index (DFI), on reproductive outcomes after assisted reproductive technology (ART).

Enrollment

1,350 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • First cycle treatment

Exclusion criteria

  • TESA/PESA, more than one cycle

Trial design

1,350 participants in 3 patient groups

IUI - Insemination
Description:
Males of couples undergoing their first IUI treatment
IVF - In vitro fertilisation
Description:
Males of couples undergoing their first IVF treatment. Including males of couples who have had previous IUI treatments.
ICSI - Micro Insemination
Description:
Males of couples undergoing their first ICSI treatment. Including males of couples who have had previous IUI treatments.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems